For citations:
Minnibaeva A.R., Artamonova E.V., Zhulikov Ya.A., Khoroshilov M.V., Kovalenko E.I. Neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) in patients with HER2-positive early or locally advanced breast cancer. Medical alphabet. 2023;(36):24-29. (In Russ.) https://doi.org/10.33667/2078-5631-2023-36-24-29